These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report. Sinawat S, Chiyabutra T, Kleabkaew P. J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963 [Abstract] [Full Text] [Related]
5. Endometrial carcinoma and tamoxifen: clearing up a controversy. Jordan VC, Assikis VJ. Clin Cancer Res; 1995 May; 1(5):467-72. PubMed ID: 9816005 [Abstract] [Full Text] [Related]
6. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. Swerdlow AJ, Jones ME, British Tamoxifen Second Cancer Study Group. J Natl Cancer Inst; 2005 Mar 02; 97(5):375-84. PubMed ID: 15741574 [Abstract] [Full Text] [Related]
7. [Cancer of the endometrium caused by antiestrogens]. Le Bouëdec G, Dauplat J. Rev Fr Gynecol Obstet; 1992 Jun 02; 87(6):345-8. PubMed ID: 1631476 [Abstract] [Full Text] [Related]
10. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: A case report and review of the literature. Schlesinger C, Silverberg SG. Gynecol Oncol; 1999 May 02; 73(2):305-11. PubMed ID: 10329051 [Abstract] [Full Text] [Related]
11. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma. Katase K, Sugiyama Y, Hasumi K, Yoshimoto M, Kasumi F. Cancer; 1998 May 01; 82(9):1698-703. PubMed ID: 9576291 [Abstract] [Full Text] [Related]